Frontiers in oncology

Apr 2, 2023 ... The AACR's Annual Meeting 2023 will be the crossroads of the cancer research world April 14-19, bringing together thousands of experts from ...

Added 14 August 2012 • Updated 12 January 2024. A peer-reviewed, open access journal in cancer research, clinical oncology, cancer genetics, molecular targets & surgical …Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.3 days ago · Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics. Special Issue Information. Dear Colleagues,. Pancreatic adenocarcinoma is an aggressive malignancy associated with poor prognosis and is the fourth most common ...Updates on Radiation-induced Lymphopenia. Peter Sylvain Nicolas van Rossum. Steven H Lin. Jian-Yue Jin. 14,906 views. 9 articles. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing …Introduction. Non-communicable Diseases (NCD) were responsible for 15 million premature deaths (30-69 years) worldwide in 2016, with more than 85% of these deaths occurring in low- and middle …

Browse the latest research topics in oncology, covering various aspects of cancer biology, diagnosis, treatment and prevention. Find articles on mitochondrial dysregulation, skull-base tumours, radiation therapy, immunotherapy, nanomaterials, and more.Priority will be given to preclinical and translational evaluations of novel targets and functioning of the target specific therapeutics. Submissions should present significant new information on the mechanisms of targetable molecules in cancer development and metastasis and target-specific therapies. Mechanistic studies that use innovative ...Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and …3 days ago · Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics. Title proper: Frontiers in oncology. Abbreviated key-title: Front. oncol. Original alphabet of title: Basic roman. Publisher: Lausanne: Frontiers Media S.A., 2011- Dates of …May 10, 2023 · Female breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ). Our ultimate goal is to provide a mechanism of communication between clinicians and researchers that will stimulate and promote a continuation of the multimodal strategies characteristic of the genitourinary oncology field. This section welcomes contributions related to both clinical and basic research findings in the various genitourinary ...

Frontiers in Oncology has an h-index of 121.It means 121 articles of this journal have more than 121 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each …Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.Frontier Communications is one of the largest telecommunications companies in the United States, providing high-speed internet, phone, and TV services to millions of customers acro...How we publish. Frontiers' approach to publishing is driven by the principle of placing publishing back into the hands of researchers, enabled by scalable technology. This means we distribute editorial responsibility to the editorial board who take acceptance or rejection decisions and have the independence to shape the direction of research.Frontier Airlines is a popular low-cost carrier that offers budget-friendly travel options for those looking to explore new destinations without breaking the bank. With a focus on ...

Microphone studio.

32. Guittet L, Quipourt V, Aparicio T, Carola E, Seitz JF, Paillaud E, et al. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD). BMC Cancer (2023) 23(1):17. doi: …Table 1: Frontiers' APCs are structured in four categories, depending on the journal's maturity and the level of research funding and/or open access funding available in various research communities. They also support article types with lower prices or articles that are free of charge. Frontiers' APCs are charged in US$.4 days ago · Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies. michael kattan. Cleveland Clinic Lerner College of Medicine, School of Medicine, Case Western Reserve University. Cleveland, United States. Specialty Chief Editor. Genitourinary Oncology. The Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers section aims at offering a wide and comprehensive approach to investigations concerning tumorigenesis, prevention, early detection and treatment of HPB neoplasia. Even though the molecular machinery triggering and sustaining HPB carcinogenesis and the morphogenetic … Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order.

May 10, 2024 · Marry M. van den Heuvel-Eibrink. Archie Bleyer. Frontiers in Oncology. doi 10.3389/fonc.2024.1336714. 838 views. Part of a multidisciplinary journal, this section publishes quality basic science, translational studies, and clinical trials in the field of pediatric oncology. 1 Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China; 2 School of Life Science, University of Chinese Academy of Sciences, Beijing, China; 3 Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China; 4 Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China; 5 …Frontiers in Oncology ... Consult your physician. Privacy Notice | Terms and Conditions of Use ©2019 PROBIOMED S.A. de C.V. | Consult your physician.Getting started. The submitting and corresponding author (s) must register and log in with Frontiers to be able to follow the review process. Ensure that your manuscript fits the scope of the journal/section/Research Topic in which it will be submitted and that you have chosen the correct article type. Submission of the wrong article type or to ...1 Introduction. The accuracy of radiotherapy is crucial to its therapeutic effects on patients. Patient-specific QA is an important standard process to identify discrepancies between the dose calculated by a treatment planning system (TPS) and that delivered by the treatment machine (1–3).For two-dimensional (2D) or three-dimensional (3D) …Jürgen Schlegel. Ekkehard Hewer. Bianca Pollo. Theoni Maragkou. Frontiers in Oncology. doi 10.3389/fonc.2024.1389608. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.Feb 28, 2023 ... In an initial trial, patients who were in remission after previously having cancer were vaccinated, with the goal of preventing recurrence. Now, ...Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ...May 10, 2024 · This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment. bipul r acharya. Cedars Sinai Medical Center. Los Angeles, United States. Associate Editor. Molecular and Cellular Oncology.Master protocols in oncology allow detection of specific signal pathways strongly associated with driver gene mutations, cancer cell growth, and progression . A basket trial is a particular type of master protocol that evaluates the efficacy and safety of a targeted therapy in multiple diseases that share a common molecular alteration ( 11 ) or ...

Apr 23, 2024 ... Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways. Rong Wang ...

Frontiers in Oncology 影响因子：4.848 Frontiers in Oral Health. P. Frontiers in Pediatrics 影响因子：2.634 Frontiers in Pharmacology 影响因子：4.225 Background. Immune checkpoint inhibitors (ICIs) are a class of antitumor drug that activate lymphocytes, which then attack tumor cells by relieving immune checkpoint-mediated immune-suppression (1, 2).In 2015, two types of ICIs (nivolumab and pembrolizumab) were approved by the U.S. Food and Drug Administration for the …Description. Frontiers in Oncology publishes articles on the most outstanding discoveries across the entire research spectrum of Oncology. The mission of Frontiers in Oncology is to bring all relevant Specialties in Oncology together on a single platform. Frontiers in Oncology is composed of the following Specialty Sections: Frontiers in Cancer ...Getting started. The submitting and corresponding author (s) must register and log in with Frontiers to be able to follow the review process. Ensure that your manuscript fits the scope of the journal/section/Research Topic in which it will be submitted and that you have chosen the correct article type. Submission of the wrong article type or to ...Immune Cell Exhaustion: New Challenges and Opportunities in Cancer Therapy. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses.Added 14 August 2012 • Updated 12 January 2024. A peer-reviewed, open access journal in cancer research, clinical oncology, cancer genetics, molecular targets & surgical oncology.Nov 25, 2022 ... Frontiers of Medical Research: Cancer ... Share: ... This Booklet is brought to you by the Science /AAAS Custom Publishing Office. Download PDF.

American dad.

Nyc to maine.

Sep 5, 2022 ... We're addressing the challenge of immune evasion from two angles. Firstly, by finding novel ways to overcome the defensive mechanisms that ...Updates on Radiation-induced Lymphopenia. Peter Sylvain Nicolas van Rossum. Steven H Lin. Jian-Yue Jin. 14,906 views. 9 articles. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing …Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.priya ranjit bhosale. University of Texas MD Anderson Cancer Center. Houston, United States. Associate Editor. Gynecological Oncology.3 Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, United States. Editorial on the Research Topic. Expert opinions in genitourinary oncology. In the last decade we have seen an explosion in the development of new treatment options, diagnostic tools, and prognostic and predictive ...May 8, 2024 · Yutaka Tamura. Kengo Yoshii. Tomoharu Sugie. Mitsugu Sekimoto. Frontiers in Oncology. doi 10.3389/fonc.2024.1365305. 844 views. This section explores high-quality research concerning all aspects of cancer and benign neoplasm drug treatment. Frontiers in Oncology. doi 10.3389/fonc.2024.1370059. 249 views Original Research. Published on 26 Apr 2024 Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis. in Radiation Oncology. Simon K. B. Spohn;Frontiers in Oncology ... Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With ...Cleveland Clinic Abu Dhabi organizes Frontiers In Advanced Hepato-Biliary Cancers And Transplant Oncology 2024, About. The Gastrointestinal Cancers: Colorectal Cancers section aims at offering a wide and comprehensive approach to investigations concerning tumorigenesis, prevention, early detection and treatment of colorectal neoplasia. Even though the molecular machinery triggering and sustaining colorectal carcinogenesis and the morphogenetic pathways leading ... 1 Hookipa Pharma Inc., New York, NY, United States; 2 Department of Biomedicine - Haus Petersplatz, Division of Experimental Virology, University of Basel, Basel, Switzerland; Engineered viral vectors represent a promising strategy to trigger antigen-specific antitumor T cell responses. Arenaviruses have been widely studied …Jürgen Schlegel. Ekkehard Hewer. Bianca Pollo. Theoni Maragkou. Frontiers in Oncology. doi 10.3389/fonc.2024.1389608. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities. ….

May 8, 2024 · Yutaka Tamura. Kengo Yoshii. Tomoharu Sugie. Mitsugu Sekimoto. Frontiers in Oncology. doi 10.3389/fonc.2024.1365305. 844 views. This section explores high-quality research concerning all aspects of cancer and benign neoplasm drug treatment. Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different ... Resurchify provides impact factor, h-index, SJR, ranking, publisher, ISSN, and other details of Frontiers in Oncology, a cancer research journal. See … Table 1: Frontiers' APCs are structured in four categories, depending on the journal's maturity and the level of research funding and/or open access funding available in various research communities. They also support article types with lower prices or articles that are free of charge. Frontiers' APCs are charged in US$. Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era. Telemedicine has historically been underutilized in medicine broadly, and specifically in oncology, despite the general availability of the needed infrastructure to offer it as a platform for remote care. The COVID-19 pandemic posed new risks of infection …Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different disciplines.Learn how to prepare and submit your manuscript to Frontiers in Oncology, a leading open access journal in the field of cancer research. Find out the article types, templates, language editing, style, keywords, and other general standards for publication. Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). Dongfeng Shen. Baoli Jin. Xueqin Wu. Frontiers in Oncology. doi 10.3389/fonc.2024.1340859. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and esophageal neoplasia.Browse the latest research topics in oncology, covering various aspects of cancer biology, diagnosis, treatment and prevention. Find articles on mitochondrial dysregulation, skull-base tumours, radiation therapy, immunotherapy, nanomaterials, and more. Frontiers in oncology, Mar 30, 2017 ... Synthetic biology promises to revolutionize cancer care by offering permanent cures to patients with historically untreatable malignancies., Are you an oncology nurse looking to expand your knowledge and advance your career? Look no further than free online oncology nursing CEU courses. Online learning has revolutionize..., Frontiers in Cardiovascular Medicine: Rising Stars 2023. Kazufumi Nakamura. Ricardo Sanz-Ruiz. David Marti. Manuel M Mazo. Diana S Nascimento. Elisa Avolio. Olaf Bergmann. Rajesh Katare., Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different ..., 4 days ago · timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology. , Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence., Frontier Airlines is a popular low-cost carrier that offers affordable flights to various destinations across the United States. If you are planning to fly with Frontier, it’s impo..., Dongfeng Shen. Baoli Jin. Xueqin Wu. Frontiers in Oncology. doi 10.3389/fonc.2024.1340859. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and esophageal neoplasia., Dec 19, 2023 ... Ministry of Education Frontiers Science Center for Precision Oncology of UM holds its first Academic Committee meeting, academicians and ..., Master protocols in oncology allow detection of specific signal pathways strongly associated with driver gene mutations, cancer cell growth, and progression . A basket trial is a particular type of master protocol that evaluates the efficacy and safety of a targeted therapy in multiple diseases that share a common molecular alteration ( 11 ) or …, Apr 2, 2023 ... The AACR's Annual Meeting 2023 will be the crossroads of the cancer research world April 14-19, bringing together thousands of experts from ..., 1 Introduction. The accuracy of radiotherapy is crucial to its therapeutic effects on patients. Patient-specific QA is an important standard process to identify discrepancies between the dose calculated by a treatment planning system (TPS) and that delivered by the treatment machine (1–3).For two-dimensional (2D) or three-dimensional (3D) …, The Cancer Genetics specialty section will facilitate the publication of high-quality original research and review articles pertaining to the genetic, genomic and molecular aspects of cancer, and technical advances that facilitate progress in this field. Focused primarily on molecular genetic aberrations driving malignant processes in human ..., Frontier Communications is a well-known provider of internet, phone, and television services. If you’re in the market for a new TV package, you might be wondering what options Fron..., Breast Cancer is a specialty section of Oncology dedicated to advancing scientific and clinical knowledge of breast cancers. This section seeks to publish articles addressing novel findings, controversies, and innovative hypotheses in the areas of prevention, diagnosis, and treatment of early breast lesions and breast malignancies., Jing Yang. Xin Li. Rong-Xia Huang. Jian Chen. Frontiers in Oncology. doi 10.3389/fonc.2024.1377486. 161 views. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence., Our vision for the program is Comprehensive Cancer Care and Optimized Cancer Survival by 2025. We hope to achieve the vision of our country, that is, the ..., Frontiers in Oncology publishes peer-reviewed articles across the entire field of cancer research, from basic to clinical. It is a multidisciplinary journal with a high impact factor and a global reach, ranking among the top journals in the category of oncology., In this Research Topic, “ Recent Advances in Boron Neutron Capture Therapy in Radiation Oncology ”, there were four papers published. Hsu et al. discussed developing a tumor control probability (TCP) model from a clinical trial done in Taiwan for recurrent head and neck (H&N) cancer. Their analysis showed the generalized Equivalent Uniform ..., Learn how to prepare and submit your manuscript to Frontiers in Oncology, a leading open access journal in the field of cancer research. Find out the articl…, 1 Introduction. Immune checkpoint molecules play a crucial role in the immune regulation of malignant tumors, and their biological significance is essential for the diagnosis, prognosis, and treatment of tumors ().Checkpoints are located on various immune cells, including T lymphocytes, or on tumor cells, and they function like switch …, Background. Immune checkpoint inhibitors (ICIs) are a class of antitumor drug that activate lymphocytes, which then attack tumor cells by relieving immune checkpoint-mediated immune-suppression (1, 2).In 2015, two types of ICIs (nivolumab and pembrolizumab) were approved by the U.S. Food and Drug Administration for the …, Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and..., Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication. For authors who would like their manuscript to receive language editing or proofreading to improve the clarity of the manuscript and help highlight their research, we recommend the language-editing services provided by the following external partners. , Alan Chu. Zongwen Liu. Jose Luis Manzano. Frontiers in Oncology. doi 10.3389/fonc.2024.1322116. 783 views. Part of a multidisciplinary journal, this section expands our understanding of molecular and cellular mechanisms involved in skin cancer progression., Jul 6, 2023 ... PDF | The latest issue of "Oncology Research" features four review articles that unveil the latest advancements in the field of cancer ..., May 10, 2024 · This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment. , Available at: https://persistent-url (Accessed March 15, 2018). This section explores basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells., Feb 28, 2023 ... In an initial trial, patients who were in remission after previously having cancer were vaccinated, with the goal of preventing recurrence. Now, ..., Table 1: Frontiers' APCs are structured in four categories, depending on the journal's maturity and the level of research funding and/or open access funding available in various research communities. They also support article types with lower prices or articles that are free of charge. Frontiers' APCs are charged in US$. , See all (60) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies., Baohua Hou. Frontiers in Oncology. doi 10.3389/fonc.2024.1332387. 161 views. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of …, Given the effective heating ability to moderate temperatures, the improved tumor perfusion, and ability to increase drug absorption, mEHT is a safe and ...